nodes	percent_of_prediction	percent_of_DWPC	metapath
Mecamylamine—Chorea—Conjugated Estrogens—prostate cancer	0.0363	0.0363	CcSEcCtD
Mecamylamine—Chorea—Estradiol—prostate cancer	0.029	0.029	CcSEcCtD
Mecamylamine—Ileus—Cabazitaxel—prostate cancer	0.0182	0.0182	CcSEcCtD
Mecamylamine—Libido decreased—Estramustine—prostate cancer	0.0135	0.0135	CcSEcCtD
Mecamylamine—Fibrosis—Capecitabine—prostate cancer	0.0133	0.0133	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Estramustine—prostate cancer	0.0124	0.0124	CcSEcCtD
Mecamylamine—Libido decreased—Nilutamide—prostate cancer	0.012	0.012	CcSEcCtD
Mecamylamine—Libido decreased—Flutamide—prostate cancer	0.0119	0.0119	CcSEcCtD
Mecamylamine—Libido decreased—Estradiol valerate/Dienogest—prostate cancer	0.0112	0.0112	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Nilutamide—prostate cancer	0.011	0.011	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Flutamide—prostate cancer	0.011	0.011	CcSEcCtD
Mecamylamine—Libido decreased—Degarelix—prostate cancer	0.0107	0.0107	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Estradiol valerate/Dienogest—prostate cancer	0.0103	0.0103	CcSEcCtD
Mecamylamine—Erectile dysfunction—Estramustine—prostate cancer	0.00996	0.00996	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Degarelix—prostate cancer	0.00984	0.00984	CcSEcCtD
Mecamylamine—Urinary retention—Cabazitaxel—prostate cancer	0.00888	0.00888	CcSEcCtD
Mecamylamine—Erectile dysfunction—Nilutamide—prostate cancer	0.00883	0.00883	CcSEcCtD
Mecamylamine—Erectile dysfunction—Flutamide—prostate cancer	0.00879	0.00879	CcSEcCtD
Mecamylamine—Libido decreased—Bicalutamide—prostate cancer	0.00864	0.00864	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Cabazitaxel—prostate cancer	0.00853	0.00853	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Bicalutamide—prostate cancer	0.00795	0.00795	CcSEcCtD
Mecamylamine—Erectile dysfunction—Degarelix—prostate cancer	0.00789	0.00789	CcSEcCtD
Mecamylamine—Urinary retention—Bicalutamide—prostate cancer	0.00762	0.00762	CcSEcCtD
Mecamylamine—Libido decreased—Ethinyl Estradiol—prostate cancer	0.0073	0.0073	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Ethinyl Estradiol—prostate cancer	0.00672	0.00672	CcSEcCtD
Mecamylamine—Erectile dysfunction—Bicalutamide—prostate cancer	0.00638	0.00638	CcSEcCtD
Mecamylamine—Libido decreased—Goserelin—prostate cancer	0.00601	0.00601	CcSEcCtD
Mecamylamine—Syncope—Nilutamide—prostate cancer	0.00599	0.00599	CcSEcCtD
Mecamylamine—Loss of consciousness—Nilutamide—prostate cancer	0.00587	0.00587	CcSEcCtD
Mecamylamine—Anorexia—Estramustine—prostate cancer	0.00586	0.00586	CcSEcCtD
Mecamylamine—Vision blurred—Degarelix—prostate cancer	0.00563	0.00563	CcSEcCtD
Mecamylamine—Ileus—Docetaxel—prostate cancer	0.00554	0.00554	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Goserelin—prostate cancer	0.00553	0.00553	CcSEcCtD
Mecamylamine—Shock—Nilutamide—prostate cancer	0.00537	0.00537	CcSEcCtD
Mecamylamine—Ileus—Capecitabine—prostate cancer	0.00536	0.00536	CcSEcCtD
Mecamylamine—Decreased appetite—Estramustine—prostate cancer	0.00534	0.00534	CcSEcCtD
Mecamylamine—Urinary retention—Goserelin—prostate cancer	0.0053	0.0053	CcSEcCtD
Mecamylamine—Anorexia—Nilutamide—prostate cancer	0.0052	0.0052	CcSEcCtD
Mecamylamine—Anorexia—Flutamide—prostate cancer	0.00518	0.00518	CcSEcCtD
Mecamylamine—Fatigue—Abiraterone—prostate cancer	0.00515	0.00515	CcSEcCtD
Mecamylamine—Constipation—Abiraterone—prostate cancer	0.00511	0.00511	CcSEcCtD
Mecamylamine—Paraesthesia—Nilutamide—prostate cancer	0.0049	0.0049	CcSEcCtD
Mecamylamine—Libido decreased—Estradiol—prostate cancer	0.00476	0.00476	CcSEcCtD
Mecamylamine—Decreased appetite—Nilutamide—prostate cancer	0.00474	0.00474	CcSEcCtD
Mecamylamine—Decreased appetite—Flutamide—prostate cancer	0.00472	0.00472	CcSEcCtD
Mecamylamine—Fatigue—Flutamide—prostate cancer	0.00468	0.00468	CcSEcCtD
Mecamylamine—Constipation—Nilutamide—prostate cancer	0.00466	0.00466	CcSEcCtD
Mecamylamine—Constipation—Flutamide—prostate cancer	0.00464	0.00464	CcSEcCtD
Mecamylamine—Erectile dysfunction—Goserelin—prostate cancer	0.00444	0.00444	CcSEcCtD
Mecamylamine—Fatigue—Estradiol valerate/Dienogest—prostate cancer	0.00442	0.00442	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Estradiol—prostate cancer	0.00438	0.00438	CcSEcCtD
Mecamylamine—Anorexia—Cabazitaxel—prostate cancer	0.00438	0.00438	CcSEcCtD
Mecamylamine—Syncope—Bicalutamide—prostate cancer	0.00433	0.00433	CcSEcCtD
Mecamylamine—Asthenia—Abiraterone—prostate cancer	0.00428	0.00428	CcSEcCtD
Mecamylamine—Loss of consciousness—Bicalutamide—prostate cancer	0.00424	0.00424	CcSEcCtD
Mecamylamine—Decreased appetite—Degarelix—prostate cancer	0.00424	0.00424	CcSEcCtD
Mecamylamine—Fatigue—Degarelix—prostate cancer	0.0042	0.0042	CcSEcCtD
Mecamylamine—Constipation—Degarelix—prostate cancer	0.00417	0.00417	CcSEcCtD
Mecamylamine—Paraesthesia—Cabazitaxel—prostate cancer	0.00412	0.00412	CcSEcCtD
Mecamylamine—Decreased appetite—Cabazitaxel—prostate cancer	0.00399	0.00399	CcSEcCtD
Mecamylamine—Fatigue—Cabazitaxel—prostate cancer	0.00396	0.00396	CcSEcCtD
Mecamylamine—Constipation—Cabazitaxel—prostate cancer	0.00393	0.00393	CcSEcCtD
Mecamylamine—Asthenia—Nilutamide—prostate cancer	0.00391	0.00391	CcSEcCtD
Mecamylamine—Vomiting—Estramustine—prostate cancer	0.00391	0.00391	CcSEcCtD
Mecamylamine—Asthenia—Flutamide—prostate cancer	0.0039	0.0039	CcSEcCtD
Mecamylamine—Dizziness—Estrone—prostate cancer	0.00388	0.00388	CcSEcCtD
Mecamylamine—Shock—Bicalutamide—prostate cancer	0.00387	0.00387	CcSEcCtD
Mecamylamine—Vomiting—Abiraterone—prostate cancer	0.0038	0.0038	CcSEcCtD
Mecamylamine—Anorexia—Bicalutamide—prostate cancer	0.00375	0.00375	CcSEcCtD
Mecamylamine—Ileus—Epirubicin—prostate cancer	0.00374	0.00374	CcSEcCtD
Mecamylamine—Vomiting—Estrone—prostate cancer	0.00373	0.00373	CcSEcCtD
Mecamylamine—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.00368	0.00368	CcSEcCtD
Mecamylamine—Nausea—Estramustine—prostate cancer	0.00365	0.00365	CcSEcCtD
Mecamylamine—Dizziness—Nilutamide—prostate cancer	0.00361	0.00361	CcSEcCtD
Mecamylamine—Dizziness—Flutamide—prostate cancer	0.00359	0.00359	CcSEcCtD
Mecamylamine—Paraesthesia—Bicalutamide—prostate cancer	0.00354	0.00354	CcSEcCtD
Mecamylamine—Asthenia—Degarelix—prostate cancer	0.0035	0.0035	CcSEcCtD
Mecamylamine—Pulmonary oedema—Docetaxel—prostate cancer	0.00349	0.00349	CcSEcCtD
Mecamylamine—Nausea—Estrone—prostate cancer	0.00349	0.00349	CcSEcCtD
Mecamylamine—Vomiting—Nilutamide—prostate cancer	0.00347	0.00347	CcSEcCtD
Mecamylamine—Ileus—Doxorubicin—prostate cancer	0.00346	0.00346	CcSEcCtD
Mecamylamine—Vomiting—Flutamide—prostate cancer	0.00345	0.00345	CcSEcCtD
Mecamylamine—Decreased appetite—Bicalutamide—prostate cancer	0.00342	0.00342	CcSEcCtD
Mecamylamine—Fatigue—Bicalutamide—prostate cancer	0.00339	0.00339	CcSEcCtD
Mecamylamine—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00339	0.00339	CcSEcCtD
Mecamylamine—Constipation—Bicalutamide—prostate cancer	0.00337	0.00337	CcSEcCtD
Mecamylamine—Asthenia—Cabazitaxel—prostate cancer	0.00329	0.00329	CcSEcCtD
Mecamylamine—Erectile dysfunction—Mitoxantrone—prostate cancer	0.00328	0.00328	CcSEcCtD
Mecamylamine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00326	0.00326	CcSEcCtD
Mecamylamine—Nausea—Nilutamide—prostate cancer	0.00324	0.00324	CcSEcCtD
Mecamylamine—Nausea—Flutamide—prostate cancer	0.00323	0.00323	CcSEcCtD
Mecamylamine—Dizziness—Degarelix—prostate cancer	0.00322	0.00322	CcSEcCtD
Mecamylamine—Vision blurred—Goserelin—prostate cancer	0.00316	0.00316	CcSEcCtD
Mecamylamine—Vision blurred—Conjugated Estrogens—prostate cancer	0.00313	0.00313	CcSEcCtD
Mecamylamine—Vomiting—Degarelix—prostate cancer	0.0031	0.0031	CcSEcCtD
Mecamylamine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00304	0.00304	CcSEcCtD
Mecamylamine—Dizziness—Cabazitaxel—prostate cancer	0.00304	0.00304	CcSEcCtD
Mecamylamine—Pulmonary oedema—Prednisone—prostate cancer	0.00301	0.00301	CcSEcCtD
Mecamylamine—Syncope—Conjugated Estrogens—prostate cancer	0.00298	0.00298	CcSEcCtD
Mecamylamine—Libido decreased—Capecitabine—prostate cancer	0.00297	0.00297	CcSEcCtD
Mecamylamine—Loss of consciousness—Conjugated Estrogens—prostate cancer	0.00292	0.00292	CcSEcCtD
Mecamylamine—Vomiting—Cabazitaxel—prostate cancer	0.00292	0.00292	CcSEcCtD
Mecamylamine—Convulsion—Goserelin—prostate cancer	0.00291	0.00291	CcSEcCtD
Mecamylamine—Nausea—Degarelix—prostate cancer	0.00289	0.00289	CcSEcCtD
Mecamylamine—Convulsion—Conjugated Estrogens—prostate cancer	0.00288	0.00288	CcSEcCtD
Mecamylamine—Fatigue—Ethinyl Estradiol—prostate cancer	0.00287	0.00287	CcSEcCtD
Mecamylamine—Glossitis—Epirubicin—prostate cancer	0.00287	0.00287	CcSEcCtD
Mecamylamine—Constipation—Ethinyl Estradiol—prostate cancer	0.00285	0.00285	CcSEcCtD
Mecamylamine—Asthenia—Bicalutamide—prostate cancer	0.00283	0.00283	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Capecitabine—prostate cancer	0.00273	0.00273	CcSEcCtD
Mecamylamine—Nausea—Cabazitaxel—prostate cancer	0.00273	0.00273	CcSEcCtD
Mecamylamine—Shock—Goserelin—prostate cancer	0.00269	0.00269	CcSEcCtD
Mecamylamine—Shock—Conjugated Estrogens—prostate cancer	0.00267	0.00267	CcSEcCtD
Mecamylamine—Glossitis—Doxorubicin—prostate cancer	0.00265	0.00265	CcSEcCtD
Mecamylamine—Urinary retention—Capecitabine—prostate cancer	0.00262	0.00262	CcSEcCtD
Mecamylamine—Anorexia—Goserelin—prostate cancer	0.00261	0.00261	CcSEcCtD
Mecamylamine—Dizziness—Bicalutamide—prostate cancer	0.0026	0.0026	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Docetaxel—prostate cancer	0.0026	0.0026	CcSEcCtD
Mecamylamine—Anorexia—Conjugated Estrogens—prostate cancer	0.00259	0.00259	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Capecitabine—prostate cancer	0.00252	0.00252	CcSEcCtD
Mecamylamine—Vomiting—Bicalutamide—prostate cancer	0.0025	0.0025	CcSEcCtD
Mecamylamine—Tremor—Estradiol—prostate cancer	0.00249	0.00249	CcSEcCtD
Mecamylamine—Paraesthesia—Goserelin—prostate cancer	0.00246	0.00246	CcSEcCtD
Mecamylamine—Paraesthesia—Conjugated Estrogens—prostate cancer	0.00244	0.00244	CcSEcCtD
Mecamylamine—Asthenia—Ethinyl Estradiol—prostate cancer	0.00239	0.00239	CcSEcCtD
Mecamylamine—Syncope—Estradiol—prostate cancer	0.00239	0.00239	CcSEcCtD
Mecamylamine—Decreased appetite—Goserelin—prostate cancer	0.00238	0.00238	CcSEcCtD
Mecamylamine—Fatigue—Goserelin—prostate cancer	0.00236	0.00236	CcSEcCtD
Mecamylamine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.00236	0.00236	CcSEcCtD
Mecamylamine—Pulmonary oedema—Epirubicin—prostate cancer	0.00235	0.00235	CcSEcCtD
Mecamylamine—Constipation—Goserelin—prostate cancer	0.00234	0.00234	CcSEcCtD
Mecamylamine—Fatigue—Conjugated Estrogens—prostate cancer	0.00234	0.00234	CcSEcCtD
Mecamylamine—Nausea—Bicalutamide—prostate cancer	0.00234	0.00234	CcSEcCtD
Mecamylamine—Loss of consciousness—Estradiol—prostate cancer	0.00234	0.00234	CcSEcCtD
Mecamylamine—Vision blurred—Mitoxantrone—prostate cancer	0.00234	0.00234	CcSEcCtD
Mecamylamine—Constipation—Conjugated Estrogens—prostate cancer	0.00232	0.00232	CcSEcCtD
Mecamylamine—Dizziness—Ethinyl Estradiol—prostate cancer	0.0022	0.0022	CcSEcCtD
Mecamylamine—Pulmonary oedema—Doxorubicin—prostate cancer	0.00218	0.00218	CcSEcCtD
Mecamylamine—Convulsion—Mitoxantrone—prostate cancer	0.00215	0.00215	CcSEcCtD
Mecamylamine—Shock—Estradiol—prostate cancer	0.00214	0.00214	CcSEcCtD
Mecamylamine—Vomiting—Ethinyl Estradiol—prostate cancer	0.00212	0.00212	CcSEcCtD
Mecamylamine—Shock—Mitoxantrone—prostate cancer	0.00199	0.00199	CcSEcCtD
Mecamylamine—Nausea—Ethinyl Estradiol—prostate cancer	0.00198	0.00198	CcSEcCtD
Mecamylamine—Asthenia—Goserelin—prostate cancer	0.00197	0.00197	CcSEcCtD
Mecamylamine—Erectile dysfunction—Prednisone—prostate cancer	0.00195	0.00195	CcSEcCtD
Mecamylamine—Paraesthesia—Estradiol—prostate cancer	0.00195	0.00195	CcSEcCtD
Mecamylamine—Asthenia—Conjugated Estrogens—prostate cancer	0.00195	0.00195	CcSEcCtD
Mecamylamine—Anorexia—Mitoxantrone—prostate cancer	0.00193	0.00193	CcSEcCtD
Mecamylamine—Decreased appetite—Estradiol—prostate cancer	0.00189	0.00189	CcSEcCtD
Mecamylamine—Fatigue—Estradiol—prostate cancer	0.00187	0.00187	CcSEcCtD
Mecamylamine—Constipation—Estradiol—prostate cancer	0.00186	0.00186	CcSEcCtD
Mecamylamine—Paraesthesia—Mitoxantrone—prostate cancer	0.00182	0.00182	CcSEcCtD
Mecamylamine—Loss of consciousness—Etoposide—prostate cancer	0.00181	0.00181	CcSEcCtD
Mecamylamine—Dizziness—Goserelin—prostate cancer	0.00181	0.00181	CcSEcCtD
Mecamylamine—Dizziness—Conjugated Estrogens—prostate cancer	0.00179	0.00179	CcSEcCtD
Mecamylamine—Convulsion—Etoposide—prostate cancer	0.00179	0.00179	CcSEcCtD
Mecamylamine—Decreased appetite—Mitoxantrone—prostate cancer	0.00176	0.00176	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Epirubicin—prostate cancer	0.00175	0.00175	CcSEcCtD
Mecamylamine—Fatigue—Mitoxantrone—prostate cancer	0.00174	0.00174	CcSEcCtD
Mecamylamine—Vomiting—Goserelin—prostate cancer	0.00174	0.00174	CcSEcCtD
Mecamylamine—Constipation—Mitoxantrone—prostate cancer	0.00173	0.00173	CcSEcCtD
Mecamylamine—Vomiting—Conjugated Estrogens—prostate cancer	0.00173	0.00173	CcSEcCtD
Mecamylamine—Nausea—Goserelin—prostate cancer	0.00163	0.00163	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Doxorubicin—prostate cancer	0.00162	0.00162	CcSEcCtD
Mecamylamine—Nausea—Conjugated Estrogens—prostate cancer	0.00161	0.00161	CcSEcCtD
Mecamylamine—Anorexia—Etoposide—prostate cancer	0.0016	0.0016	CcSEcCtD
Mecamylamine—Vision blurred—Capecitabine—prostate cancer	0.00156	0.00156	CcSEcCtD
Mecamylamine—Asthenia—Estradiol—prostate cancer	0.00156	0.00156	CcSEcCtD
Mecamylamine—Tremor—Capecitabine—prostate cancer	0.00155	0.00155	CcSEcCtD
Mecamylamine—Syncope—Docetaxel—prostate cancer	0.00154	0.00154	CcSEcCtD
Mecamylamine—Paraesthesia—Etoposide—prostate cancer	0.00151	0.00151	CcSEcCtD
Mecamylamine—Loss of consciousness—Docetaxel—prostate cancer	0.00151	0.00151	CcSEcCtD
Mecamylamine—Syncope—Capecitabine—prostate cancer	0.00149	0.00149	CcSEcCtD
Mecamylamine—Convulsion—Docetaxel—prostate cancer	0.00148	0.00148	CcSEcCtD
Mecamylamine—Decreased appetite—Etoposide—prostate cancer	0.00146	0.00146	CcSEcCtD
Mecamylamine—Loss of consciousness—Capecitabine—prostate cancer	0.00146	0.00146	CcSEcCtD
Mecamylamine—Asthenia—Mitoxantrone—prostate cancer	0.00145	0.00145	CcSEcCtD
Mecamylamine—Fatigue—Etoposide—prostate cancer	0.00145	0.00145	CcSEcCtD
Mecamylamine—Constipation—Etoposide—prostate cancer	0.00144	0.00144	CcSEcCtD
Mecamylamine—Dizziness—Estradiol—prostate cancer	0.00144	0.00144	CcSEcCtD
Mecamylamine—Vision blurred—Prednisone—prostate cancer	0.00139	0.00139	CcSEcCtD
Mecamylamine—Vomiting—Estradiol—prostate cancer	0.00138	0.00138	CcSEcCtD
Mecamylamine—Shock—Docetaxel—prostate cancer	0.00138	0.00138	CcSEcCtD
Mecamylamine—Anorexia—Docetaxel—prostate cancer	0.00133	0.00133	CcSEcCtD
Mecamylamine—Shock—Capecitabine—prostate cancer	0.00133	0.00133	CcSEcCtD
Mecamylamine—Syncope—Prednisone—prostate cancer	0.00133	0.00133	CcSEcCtD
Mecamylamine—Loss of consciousness—Prednisone—prostate cancer	0.0013	0.0013	CcSEcCtD
Mecamylamine—Anorexia—Capecitabine—prostate cancer	0.00129	0.00129	CcSEcCtD
Mecamylamine—Nausea—Estradiol—prostate cancer	0.00129	0.00129	CcSEcCtD
Mecamylamine—Vomiting—Mitoxantrone—prostate cancer	0.00129	0.00129	CcSEcCtD
Mecamylamine—Convulsion—Prednisone—prostate cancer	0.00128	0.00128	CcSEcCtD
Mecamylamine—Paraesthesia—Docetaxel—prostate cancer	0.00126	0.00126	CcSEcCtD
Mecamylamine—Paraesthesia—Capecitabine—prostate cancer	0.00122	0.00122	CcSEcCtD
Mecamylamine—Decreased appetite—Docetaxel—prostate cancer	0.00122	0.00122	CcSEcCtD
Mecamylamine—Asthenia—Etoposide—prostate cancer	0.00121	0.00121	CcSEcCtD
Mecamylamine—Fatigue—Docetaxel—prostate cancer	0.00121	0.00121	CcSEcCtD
Mecamylamine—Nausea—Mitoxantrone—prostate cancer	0.0012	0.0012	CcSEcCtD
Mecamylamine—Constipation—Docetaxel—prostate cancer	0.0012	0.0012	CcSEcCtD
Mecamylamine—Shock—Prednisone—prostate cancer	0.00119	0.00119	CcSEcCtD
Mecamylamine—Decreased appetite—Capecitabine—prostate cancer	0.00118	0.00118	CcSEcCtD
Mecamylamine—Fatigue—Capecitabine—prostate cancer	0.00117	0.00117	CcSEcCtD
Mecamylamine—Constipation—Capecitabine—prostate cancer	0.00116	0.00116	CcSEcCtD
Mecamylamine—Anorexia—Prednisone—prostate cancer	0.00115	0.00115	CcSEcCtD
Mecamylamine—Dizziness—Etoposide—prostate cancer	0.00111	0.00111	CcSEcCtD
Mecamylamine—Vision blurred—Epirubicin—prostate cancer	0.00109	0.00109	CcSEcCtD
Mecamylamine—Paraesthesia—Prednisone—prostate cancer	0.00108	0.00108	CcSEcCtD
Mecamylamine—Vomiting—Etoposide—prostate cancer	0.00107	0.00107	CcSEcCtD
Mecamylamine—Decreased appetite—Prednisone—prostate cancer	0.00105	0.00105	CcSEcCtD
Mecamylamine—Fatigue—Prednisone—prostate cancer	0.00104	0.00104	CcSEcCtD
Mecamylamine—Syncope—Epirubicin—prostate cancer	0.00104	0.00104	CcSEcCtD
Mecamylamine—Constipation—Prednisone—prostate cancer	0.00103	0.00103	CcSEcCtD
Mecamylamine—Loss of consciousness—Epirubicin—prostate cancer	0.00102	0.00102	CcSEcCtD
Mecamylamine—Vision blurred—Doxorubicin—prostate cancer	0.00101	0.00101	CcSEcCtD
Mecamylamine—Asthenia—Docetaxel—prostate cancer	0.001	0.001	CcSEcCtD
Mecamylamine—Convulsion—Epirubicin—prostate cancer	0.001	0.001	CcSEcCtD
Mecamylamine—Nausea—Etoposide—prostate cancer	0.001	0.001	CcSEcCtD
Mecamylamine—Asthenia—Capecitabine—prostate cancer	0.000972	0.000972	CcSEcCtD
Mecamylamine—Syncope—Doxorubicin—prostate cancer	0.000959	0.000959	CcSEcCtD
Mecamylamine—Loss of consciousness—Doxorubicin—prostate cancer	0.00094	0.00094	CcSEcCtD
Mecamylamine—Shock—Epirubicin—prostate cancer	0.000928	0.000928	CcSEcCtD
Mecamylamine—Convulsion—Doxorubicin—prostate cancer	0.000927	0.000927	CcSEcCtD
Mecamylamine—Dizziness—Docetaxel—prostate cancer	0.000925	0.000925	CcSEcCtD
Mecamylamine—Anorexia—Epirubicin—prostate cancer	0.000899	0.000899	CcSEcCtD
Mecamylamine—Dizziness—Capecitabine—prostate cancer	0.000895	0.000895	CcSEcCtD
Mecamylamine—Vomiting—Docetaxel—prostate cancer	0.000889	0.000889	CcSEcCtD
Mecamylamine—Asthenia—Prednisone—prostate cancer	0.000865	0.000865	CcSEcCtD
Mecamylamine—Vomiting—Capecitabine—prostate cancer	0.000861	0.000861	CcSEcCtD
Mecamylamine—Shock—Doxorubicin—prostate cancer	0.000859	0.000859	CcSEcCtD
Mecamylamine—Paraesthesia—Epirubicin—prostate cancer	0.000847	0.000847	CcSEcCtD
Mecamylamine—Anorexia—Doxorubicin—prostate cancer	0.000832	0.000832	CcSEcCtD
Mecamylamine—Nausea—Docetaxel—prostate cancer	0.000831	0.000831	CcSEcCtD
Mecamylamine—Decreased appetite—Epirubicin—prostate cancer	0.00082	0.00082	CcSEcCtD
Mecamylamine—Fatigue—Epirubicin—prostate cancer	0.000813	0.000813	CcSEcCtD
Mecamylamine—Constipation—Epirubicin—prostate cancer	0.000807	0.000807	CcSEcCtD
Mecamylamine—Nausea—Capecitabine—prostate cancer	0.000804	0.000804	CcSEcCtD
Mecamylamine—Dizziness—Prednisone—prostate cancer	0.000798	0.000798	CcSEcCtD
Mecamylamine—Paraesthesia—Doxorubicin—prostate cancer	0.000784	0.000784	CcSEcCtD
Mecamylamine—Vomiting—Prednisone—prostate cancer	0.000767	0.000767	CcSEcCtD
Mecamylamine—Decreased appetite—Doxorubicin—prostate cancer	0.000759	0.000759	CcSEcCtD
Mecamylamine—Fatigue—Doxorubicin—prostate cancer	0.000753	0.000753	CcSEcCtD
Mecamylamine—Constipation—Doxorubicin—prostate cancer	0.000746	0.000746	CcSEcCtD
Mecamylamine—Nausea—Prednisone—prostate cancer	0.000716	0.000716	CcSEcCtD
Mecamylamine—Asthenia—Epirubicin—prostate cancer	0.000677	0.000677	CcSEcCtD
Mecamylamine—Asthenia—Doxorubicin—prostate cancer	0.000626	0.000626	CcSEcCtD
Mecamylamine—Dizziness—Epirubicin—prostate cancer	0.000624	0.000624	CcSEcCtD
Mecamylamine—Vomiting—Epirubicin—prostate cancer	0.0006	0.0006	CcSEcCtD
Mecamylamine—Dizziness—Doxorubicin—prostate cancer	0.000577	0.000577	CcSEcCtD
Mecamylamine—Nausea—Epirubicin—prostate cancer	0.00056	0.00056	CcSEcCtD
Mecamylamine—Vomiting—Doxorubicin—prostate cancer	0.000555	0.000555	CcSEcCtD
Mecamylamine—Nausea—Doxorubicin—prostate cancer	0.000518	0.000518	CcSEcCtD
